Related by context. All words. (Click for frequent words.) 76 squamous cell cancer 72 squamous cell carcinomas 70 squamous cell cancers 69 basal cell carcinomas 69 Basal cell 69 squamous cell carcinoma 68 basal cell 68 squamous cell skin 68 nonmelanoma skin cancers 67 basal cell cancer 67 bladder cancers 67 esophageal cancers 67 cell carcinoma 66 testicular cancers 66 basal cell cancers 65 carcinoma 65 adenocarcinoma 65 endometrial cancers 65 leiomyosarcoma 65 anal cancers 65 Adenocarcinoma 64 ovarian breast 64 basal cell carcinoma BCC 64 basal cell carcinoma 64 basal cell skin 64 carcinomas 64 GISTs 64 invasive carcinoma 64 superficial basal cell carcinoma 64 osteosarcomas 64 squamous 64 ovarian lung 64 cancers 63 Squamous cell 63 Papillary 63 adenocarcinomas 63 Squamous cell carcinomas 63 Basal cell carcinoma 63 gastrointestinal stromal tumor 63 premalignant 63 squamous cell carcinoma SCC 63 neuroendocrine tumors 63 esophagogastric junction 63 nonsmall cell lung cancer 63 advanced adenomas 63 anaplastic 63 lung cancers 62 melanoma 62 gastrointestinal stromal tumors 62 prostate cancers 62 differentiated thyroid 62 papillary 62 nasopharyngeal cancer 62 pancreatic adenocarcinoma 62 malignant melanoma 62 medullary thyroid cancer 62 nodular melanoma 62 cell carcinomas 62 epithelial cancers 62 oropharyngeal cancer 62 invasive ductal carcinoma 62 gastric cancers 62 HER2 positive cancers 62 squamous cell lung cancer 62 nonmelanoma skin cancer 62 repigmentation 61 HNSCC 61 skeletal metastases 61 pancreatic prostate 61 prostate pancreatic 61 solar keratosis 61 carcinoid 61 Squamous cell carcinoma 61 pancreatic lung 61 skin cancers 61 actinic keratoses 61 keloids 61 colorectal lung 61 uveal melanoma 61 metastatic colorectal 61 breast pancreatic 61 malignant pleural mesothelioma 61 carcinoid tumors 61 cervical carcinoma 61 gastrointestinal cancers 61 adenomatous polyps 61 Squamous Cell Carcinoma 61 liver metastases 61 grade cervical intraepithelial 61 Squamous 61 adenoma 61 ductal breast cancer 61 gastrointestinal stromal tumor GIST 61 endometrial hyperplasia 61 lobular carcinoma 61 papillary renal cell carcinoma 61 Squamous cell cancer 61 grade gliomas 61 epithelial tumors 60 cutaneous melanoma 60 axillary lymph nodes 60 pancreatic cancers 60 cutaneous squamous cell carcinoma 60 ovarian pancreatic 60 pulmonary metastases 60 hepatocellular cancer 60 lung carcinomas 60 pre cancerous 60 metachronous 60 malignancies 60 premalignant lesions 60 non squamous NSCLC 60 precursor lesions 60 melanomas 60 histological subtype 60 penile cancers 60 dysplastic lesions caused 60 preoperative chemotherapy 60 renal cell carcinomas 60 invasive ductal 60 metastatic bladder 60 epithelial ovarian 60 Glioblastoma Multiforme GBM 60 precancerous condition 60 overexpress HER2 60 metastatic adenocarcinoma 60 esophageal adenocarcinoma 60 basal cell nevus syndrome 60 neoplasias 60 atypical hyperplasia 60 nonmelanoma 60 ADPKD 60 colorectal cancers 60 serous ovarian cancer 60 advanced adenoma 60 precancers 60 CIN3 60 HER2 positive 59 BRCA deficient 59 peritoneal cancer 59 neurofibromas 59 carcinoid cancer 59 adenoid cystic carcinoma 59 Uterine fibroids 59 bladder prostate 59 neuroendocrine cancers 59 Metastatic breast cancer 59 ocular melanoma 59 colorectum 59 malignant melanomas 59 precancerous lesion 59 bowel cancers 59 pre cancerous growths 59 dysplastic nevi 59 precancerous cervical lesions 59 metastatic lesions 59 atypical ductal hyperplasia 59 metastatic 59 lobular cancer 59 pleural mesothelioma 59 metastatic basal cell 59 rectal cancers 59 neuroendocrine carcinoma 59 fallopian tube carcinoma 59 pre cancerous lesion 59 curable cancers 59 HER2 positive tumors 59 ductal cancer 59 breast carcinomas 59 papilloma 59 Hurthle cell 59 sarcoma 59 meningioma 59 colon esophageal 59 actinic keratosis 59 colon cancers 59 Malignant melanoma 59 meningiomas 59 squamous histology 59 colorectal pancreatic 59 axillary dissection 59 fibroadenomas 59 pituitary adenomas 59 gastrointestinal stromal tumors GIST 59 ovarian carcinoma 59 hormonal therapies 59 oral squamous cell 59 cervical dysplasia 59 lobular breast cancer 59 Cholangiocarcinoma 59 subependymal giant cell 59 situ CIS 59 estrogen receptor positive 59 metastatic pancreatic 59 uterine cancers 59 systemic scleroderma 59 recurrent NSCLC 59 hormone receptor negative 59 lung pancreatic 59 intestinal polyps 59 colorectal gastric 59 uterine tumors 59 pre cancerous actinic 59 hypertrophic scars 59 nodal metastasis 58 surgically resectable 58 Glioblastoma multiforme GBM 58 glioblastoma multiforme GBM 58 leukemias lymphomas 58 metastatic gastric 58 carcinoid tumor 58 bile duct cancers 58 breast endometrial 58 Acute myeloid leukemia 58 Acute lymphoblastic leukemia 58 tumors 58 pancreatic NET 58 metastatic lung cancer 58 thymoma 58 pre cancerous polyps 58 glioblastomas 58 noncancerous tumors 58 lymphomas 58 node metastases 58 Metastatic 58 precancerous 58 neoadjuvant therapy 58 lichen planus 58 HER2 amplified 58 poorer prognosis 58 angiosarcoma 58 bladder ovarian 58 transitional cell carcinoma 58 gemcitabine chemotherapy 58 adenomas 58 chronic periodontitis 58 precancer 58 HBeAg negative 58 distant metastasis 58 Barrett esophagus 58 follicular lymphoma FL 58 situ LCIS 58 breast carcinoma 58 ASCUS 58 pre cancerous lesions 58 astrocytoma 58 colorectal liver metastases 58 GBMs 58 hormone receptor positive 58 Adjuvant chemotherapy 58 dysplasia 58 pancreatic bladder 58 benign breast 58 metastatic prostate cancer 58 unresectable 58 castration resistant 58 recurrent metastatic 58 ovarian cancers 58 medically inoperable 58 malignant cancerous 58 keratoses 58 cholangiocarcinoma 58 relapsing remitting 58 lung metastases 58 platinum refractory 58 recurrent glioblastoma multiforme 58 MALT lymphoma 58 distant metastases 57 breast cancers 57 gliomas 57 hypereosinophilic syndrome 57 colorectal neoplasms 57 Carcinoid tumors 57 cancerous enlargement 57 nasopharyngeal carcinoma 57 seminomas 57 Peritoneal mesothelioma 57 intra arterial chemotherapy 57 prostate bladder 57 unresectable tumors 57 squamous cells 57 Gorlin syndrome 57 resectable 57 histologic subtype 57 pancreatic islet cell 57 gastric pancreatic 57 Sjögren syndrome 57 pancreatic gastric 57 neoplasms 57 locoregional recurrence 57 soft tissue sarcomas 57 leukaemias 57 PNET 57 HER2 amplification 57 neoplasia 57 precancerous lesions 57 vaginal lesions 57 KRAS mutations occur 57 colorectal cancer 57 tyrosine kinase inhibitors TKIs 57 thyroid nodules 57 fibrocystic disease 57 myelofibrosis polycythemia vera 57 axilla 57 malignancy 57 pheochromocytomas 57 synovial sarcoma 57 invasive lobular 57 urothelial carcinoma 57 leiomyomas 57 IV melanoma 57 neoplastic lesions 57 situ DCIS 57 radiofrequency ablation RFA 57 estrogen receptor negative 57 stage IIIB IV 57 invasive lobular carcinoma 57 inflammatory acne 57 mycosis fungoides 57 KRAS wild 57 pediatric acute lymphoblastic 57 neoplasm 57 Basal Cell 57 metastatic colon cancer 57 Carcinoma 57 benign noncancerous 57 lung colorectal 57 colon pancreas 57 colorectal polyp 57 acoustic neuromas 57 keloid 57 squamous non 57 tumors GIST 57 lymphocytic leukemia 57 gynecological cancers 57 penile anal 57 lymph node removal 57 Testicular cancer 57 cytoreduction 57 lung adenocarcinomas 57 Glioblastoma 57 lung tumors 57 malignant pleural mesothelioma MPM 57 malignant brain 57 brain metastases 57 HER2 receptor 57 cell lung cancer 57 cisplatin chemotherapy 57 colorectal breast 57 prostate carcinoma 57 renal cell carcinoma 57 imatinib Gleevec 57 bladder tumors 57 melanoma skin 57 neuroblastomas 57 metastatic kidney 57 Melanomas 57 histologies 57 leukemia AML 57 unresectable stage 57 keloid scars 57 Hashimoto thyroiditis 57 oligodendrogliomas 57 paragangliomas 57 lung cancer NSCLC 57 lymph node metastases 56 colorectal carcinoma 56 papillary carcinoma 56 hepatocellular carcinoma HCC 56 epithelioid 56 gastric adenocarcinoma 56 geographic atrophy 56 sarcomatoid 56 intravenous bisphosphonates 56 keloid scarring 56 pheochromocytoma 56 prostate lung 56 lung colon 56 HER2 positive breast 56 lung prostate 56 CIN3 + 56 histologically confirmed 56 causes genital warts 56 benign proliferative breast 56 Glioblastoma Multiforme 56 Endometrial cancer 56 benign growths 56 carcinoma HCC 56 malignant lymphoma 56 PCNSL 56 ovarian uterine 56 removed laparoscopically 56 leukoplakia 56 metastatic GIST 56 contralateral breast 56 glioma tumors 56 squamous carcinoma 56 leukemia multiple myeloma 56 Wilms tumor 56 sarcomas 56 lymph node involvement 56 seminoma 56 adenomatous 56 standard chemotherapy regimens 56 cancerous breast 56 breast ovarian 56 uterine ovarian 56 operable breast cancer 56 vulvar intraepithelial neoplasia 56 Anaplastic 56 cancerous lesions 56 Recurrences 56 renal tumors 56 Synovial sarcoma 56 metastases 56 lobular 56 advanced unresectable 56 metastatic cancers 56 infiltrative 56 BRCA1 mutation carriers 56 glioblastoma 56 metastatic disease 56 trans retinoic acid 56 neoadjuvant treatment 56 HER2 positivity 56 Metastases 56 hypopharynx 56 Renal cell carcinoma 56 breast tumors 56 ductal carcinoma 56 ovarian endometrial 56 varices 56 cutaneous lupus 56 peritoneal carcinomatosis 56 Surgical resection 56 metastatic cancer 56 anal lesions 56 CYT# potent vascular disrupting 56 EGFR mutation positive 56 proximal colon 56 lymph node enlargement 56 Hodgkin lymphomas 56 underarm lymph nodes 56 Acoustic neuromas 56 vulvar cancers 56 breast ovary 56 gastrointestinal tumors GIST 56 prostate adenocarcinoma 56 premalignant lesion 56 embryonal rhabdomyosarcoma 56 ErbB2 positive 56 sentinel lymph node biopsy 56 intraepithelial neoplasia 56 Wilms tumors 56 liposarcoma 56 corticosteroid therapy 56 micrometastases 56 colorectal 56 lung adenocarcinoma 56 colorectal tumors 56 lung metastasis 56 essential thrombocythemia 56 EGFR inhibitors 56 stage IIIB 56 metastatic tumors 56 myeloid leukemia 56 ductal carcinomas 56 nonmetastatic 56 unresectable locally advanced 56 Colorectal cancers 56 detecting precancerous 56 chondrosarcoma 56 stage IIIA 56 bronchogenic carcinoma 56 solar keratoses 56 thoracoscopic lobectomy 56 metastatic lymph nodes 56 Gastric cancer 56 acute myeloid 56 solid tumors 56 cell lymphoma CTCL 56 HPV# 56 malignant gliomas 56 noncancerous 56 polyp recurrence 56 malignant fibrous histiocytoma 56 invasive ductal breast cancer 56 Genital warts 56 Cell Lung Cancer 56 Leukemias 56 non squamous 56 advanced epithelial ovarian 56 esophageal tumors 56 gastroesophageal junction 56 cervical lymph nodes 56 benign moles 56 EGFr 56 prostate TURP 56 Brain metastases 56 Candida infection 56 cetuximab Erbitux 56 taxane chemotherapy 56 metastatic carcinoma 55 malignant growths 55 hepatocellular carcinoma 55 ANCA associated 55 cervical breast 55 urine cytology 55 chemoradiotherapy 55 pancreatic colon 55 bone metastasis 55 Pancreatic neuroendocrine tumors 55 palliative radiotherapy 55 recurrent squamous cell carcinoma 55 neck squamous cell 55 polyps growths 55 precancerous tumors 55 colorectal adenoma 55 liver metastasis 55 nevus 55 wedge resection 55 axillary nodes 55 MGUS 55 Barrett mucosa 55 carcinoma HNSCC 55 vulvar cancer 55 melasma 55 untreated celiac disease 55 papular 55 metastatic liver 55 fallopian tube cancers 55 Squamous Cell 55 resistant hormone refractory 55 BRCA mutation carriers 55 malignant neoplasm 55 GIST tumors 55 recurrent glioblastoma 55 cancerous growths 55 benign polyps 55 cervical cancers 55 anaplastic astrocytoma 55 alkylating agents 55 LHRH receptor positive 55 Follicular lymphoma 55 metastatic breast 55 frequently benign tumor 55 hematological diseases 55 Pleural mesothelioma 55 colorectal polyps 55 NSCLC 55 Glioma 55 hypopigmentation 55 papillomas 55 apocrine 55 ALA PDT 55 non resectable metastatic 55 factor receptor EGFR 55 precancerous polyp 55 proliferative diabetic retinopathy 55 thromboembolic events 55 tumor recurrence 55 cirrhosis liver failure 55 vaginal cancers 55 HER2 positive breast cancer 55 metastatic relapsed 55 erlotinib Tarceva 55 alveolar rhabdomyosarcoma 55 heterozygous FH 55 dysplastic lesions 55 colorectal ovarian 55 cisplatin resistant 55 follicular thyroid cancer 55 papillary thyroid cancer 55 lung cancer 55 renal carcinoma 55 fibrocystic changes 55 oesophageal squamous cell carcinoma 55 luteinizing hormone releasing 55 discoid lupus 55 comedones 55 astrocytomas 55 ano genital warts 55 childhood sunburns 55 intra abdominal infections 55 liver scarring 55 ALCL 55 pilocytic astrocytomas 55 Surgical excision 55 gastric cancer 55 PSADT 55 B7 H3 55 microbleeds 55 EGFR mutation 55 hyperplastic 55 fibroadenoma 55 Barrett esophagus BE 55 painless lump 55 estrogen receptor ER 55 metastatic melanomas 55 metastatic RCC 55 benign neoplasms 55 resectable pancreatic cancer 55 FOLFIRI alone 55 Actinic Keratosis 55 Polyps 55 colorectal cancer CRC 55 metastatic malignant melanoma 55 acne vulgaris 55 malignant pheochromocytoma 55 Wegener granulomatosis 55 hamartomas 55 adrenocortical cancer 55 thyroid cancers 55 Candida infections 55 pancreatic ovarian 55 Basal cell carcinomas 55 pancreatic colorectal 55 Human papilloma virus 55 androgenetic alopecia 55 sentinel nodes 55 myelogenous leukemia 55 Peginterferon alfa 2b 55 Colon polyps 55 B Cell Lymphoma 55 hormone refractory prostate 55 anti angiogenic therapy 55 Osteosarcoma 55 chronic prostatitis 55 lipomas 55 primitive neuroectodermal tumor 55 indolent NHL 55 small lymphocytic lymphoma 55 SOD2 gene 55 Adenomas 55 biliary tract cancer 55 liver cancer 55 myeloproliferative disorders 55 parathyroid carcinoma 55 grade dysplasia 55 precancerous spots 55 glioblastoma multiforme 55 candidemia 55 benign lesions 55 benign nodules 55 HER2 positive metastatic breast 55 metastatic brain tumor 55 hepatocellular carcinomas 55 lymphoma subtypes 55 pleomorphic 55 Sezary syndrome 55 Metastatic melanoma 55 mesotheliomas 55 choroidal neovascularization CNV 55 colorectal adenocarcinoma 55 intestinal metaplasia 55 metastatic HER2 positive 55 gastric carcinoma 55 Benign prostatic hyperplasia BPH 55 liposomal doxorubicin 55 Sjogren syndrome 55 TACE 55 scaly patches 55 Rectal cancer 55 bullous 54 gastrointestinal stromal 54 mesothelium 54 mucositis 54 ovarian cervical 54 malignant tumors 54 mucinous 54 cancerous polyp 54 melanoma lesions 54 oral clodronate 54 gastrointestinal malignancies 54 heavily pretreated 54 colorectal bladder 54 leiomyoma 54 metastatic prostate 54 metastatic renal cell 54 polypoid 54 non resectable 54 colon tumors 54 severe oral mucositis 54 Medulloblastoma 54 Hepatocellular Carcinoma HCC 54 dexrazoxane 54 papules 54 alpha interferons 54 tumor histology 54 Li Fraumeni Syndrome 54 Burkitt lymphoma 54 smoldering myeloma 54 relapsed SCLC 54 Non Hodgkin lymphoma 54 acute leukemias 54 neoplastic 54 seborrheic keratoses 54 oesophageal 54 osteosarcoma rare 54 Hurler syndrome 54 laryngeal cancer 54 salpingo oophorectomy 54 BCG refractory 54 postoperative pathology 54 esophageal squamous cell carcinoma 54 ependymoma 54 tumor xenograft models 54 pemphigus vulgaris 54 neurofibroma 54 cancer 54 thromboembolic disease 54 minimally symptomatic 54 para aortic 54 oropharynx 54 receptor tyrosine kinase inhibitor 54 colon lung 54 Vulvar 54 intracranial tumors 54 cholelithiasis 54 lung ovarian 54 cervical uterine 54 malignant lesions 54 atopic dermatitis AD 54 hyperplastic polyps 54 Gliomas 54 Acute Myelogenous Leukemia 54 hepatorenal syndrome 54 hormonally responsive 54 cervical intraepithelial neoplasia 54 polycythemia vera 54 lymphoproliferative disorders 54 FOLFOX6 54 grade serous ovarian 54 TTF Therapy 54 Stomatitis 54 Chronic lymphocytic leukemia 54 invasive ductal cancer 54 HER2 + 54 cervical lesions 54 homozygous familial hypercholesterolemia 54 metastatic malignant 54 myelodysplasia 54 lymphoma 54 lumbar disk herniation 54 cT3 prostate cancer 54 vWD 54 cell lymphoma ALCL 54 HGPIN 54 systemic ALCL 54 pituitary adenoma 54 TNF blocker therapy 54 pancreatic neuroendocrine 54 non metastatic osteosarcoma 54 cervical cancer genital warts 54 K ras mutations 54 recurrent ovarian cancer 54 Mohs micrographic surgery 54 Myelodysplastic syndromes MDS 54 external genital lesions 54 eccrine 54 rhabdomyosarcoma 54 CIN2 54 prostate cancer mCRPC 54 benign tumors 54 radiosensitive 54 Nodules 54 hematologic toxicity 54 GBM tumors 54 prostate colon 54 malignant polyps 54 cervix vagina 54 prophylactic cranial irradiation 54 laryngeal cancers 54 NOLVADEX 54 hypercalcemia 54 esophageal gastric 54 lymphoma CTCL 54 endometrial carcinoma 54 radiochemotherapy 54 chemoradiation therapy 54 Radiofrequency ablation 54 acne rosacea 54 cytoreductive surgery 54 testicular tumors 54 Endometrial 54 chemotherapeutic regimens 54 lung nodules 54 pituitary tumors 54 Glioblastomas 54 nonalcoholic steatohepatitis 54 RET PTC rearrangements 54 neuroblastoma tumors 54 oesophageal cancer 54 Irinotecan 54 androgen independent 54 PUVA 54 progesterone receptor negative 54 oropharyngeal 54 receiving chemoradiation therapy 54 myelomas 54 esophageal resection 54 epithelial ovarian cancer 54 5-FU/LV 54 pancreatic carcinoma 54 metastatic HER2 negative 54 Esophageal cancer 54 bilateral oophorectomy 54 breast uterine 54 invasive cervical cancer 54 esophagitis 54 estramustine 54 paraganglioma 54 prostate breast 54 Kaposi sarcoma 54 Multiple myeloma 54 severe neutropenia 54 Atopic eczema 54 metastatic melanoma 54 anti angiogenic agents 54 squamous cell histology 54 erythematosus 54 colorectal prostate 54 curative resection 54 SLNB 54 metastatic renal 54 neoadjuvant chemotherapy 54 polyps 54 axillary lymph node dissection 54 obstructive coronary 54 gefitinib Iressa 54 sentinel node 54 adhesion molecule EpCAM expressing 54 haematologic malignancies 54 cystic lesions 54 primary peritoneal 54 castration resistant prostate cancer 54 stage IIIb IV 54 nevi 54 radiation therapy SBRT 54 nonmalignant 54 BRCA2 mutations 54 NMIBC 54 mycophenolate mofetil 54 EGFR protein 54 ovarian colon 54 plaque psoriasis 54 hormone receptor status 53 leukemias 53 vinca alkaloids 53 thyroid tumors 53 cytologically confirmed 53 colonic polyps 53 metastatic colorectal cancer 53 malignant prostate 53 surgical biopsy 53 neovascular 53 advanced metastatic renal 53 common hematologic malignancy 53 scleroderma 53 ductal 53 hormone deprivation 53 chemoradiation 53 severe periodontitis 53 Fibroid tumors 53 endometrioid 53 malignant neoplasms 53 Philadelphia Chromosome Positive 53 cervical vaginal 53 post transplant lymphoproliferative 53 superficial basal cell carcinomas 53 Acute myeloid leukemia AML 53 atypia 53 myeloproliferative diseases 53 pharyngeal cancer 53 xerostomia 53 prostate walnut 53 gastrointestinal GI cancers 53 Ductal carcinoma 53 prostate carcinomas 53 glandular tissue 53 myelodysplastic syndrome MDS 53 invasive ductal carcinomas 53 surgical excision 53 intravesical therapy 53 alkylating agent 53 colorectal liver 53 nodular 53 Neurofibromatosis type 53 Malignant Melanoma 53 osteogenic sarcoma 53 leucopenia 53 androgen ablation 53 Kit CD# positive 53 gemcitabine carboplatin 53 acute lymphoid leukemia 53 chemoembolization 53 hematologic malignancies 53 aerodigestive tract 53 Soft Tissue Sarcoma 53 endometrial ovarian 53 fibrin deposition 53 macroalbuminuria 53 leukemia ALL 53 posterior uveitis 53 Cutaneous T 53 BRAF mutations 53 castrate resistant prostate cancer 53 metastatic renal cell carcinoma 53 endometrial cancer 53 hormone refractory 53 precancerous cervical 53 abnormal growths 53 EGFR mutations 53 GSTT1 53 precancerous tissue 53 total thyroidectomy 53 oesophageal adenocarcinoma 53 splenectomized patients 53 refractory gastrointestinal stromal 53 intraperitoneal therapy 53 solar lentigines 53 uterine fibroid 53 malignant lesion 53 Toxicities 53 medulloblastoma 53 advanced hepatocellular carcinoma 53 ovarian colorectal 53 bladder cervix 53 nonproliferative 53 distal colon 53 Pemetrexed 53 SCCHN 53 Plantar warts 53 mammary tumors 53 histological subtypes 53 Malignant gliomas 53 squamous skin 53 oophorectomy 53 chronic myeloid 53 GSTP1 53 moderate renal impairment 53 follicular lymphoma 53 endocrine therapies 53 imatinib resistance 53 tumor 53 FSGS 53 choroidal neovascularization 53 GnRH agonists 53 allograft rejection 53 taxane therapy 53 CMV disease 53 Vicinium TM 53 carotid stenosis 53 colon cancer 53 cutaneous T cell 53 cervical ovarian 53 HER2 expression 53 bacteriuria 53 antiestrogen 53 SUVmax 53 EGFR expressing 53 Epstein Barr virus EBV 53 malignant mesothelioma 53 subclinical hyperthyroidism 53 chronic eosinophilic leukemia 53 Paraplatin ® carboplatin 53 multiforme 53 prostate tumor 53 colon polyps 53 nonfunctioning kidneys 53 ccRCC 53 localized prostate 53 lymphoid malignancies 53 cancer mCRC 53 Meningiomas 53 ADAM# 53 Glioblastoma multiforme 53 Recombinant interferon alpha 53 chlorambucil 53 sarcoid 53 lobular carcinomas 53 Malignant mesothelioma 53 Precancerous 53 GIST 53 metastatic medullary thyroid 53 myelodysplastic syndromes 53 completely resected 53 adjuvant radiation 53 bacterial conjunctivitis 53 ALND 53 IV metastatic melanoma 53 axillary node dissection 53 pulmonary hypertension PH 53 CLL SLL 53 hormonally sensitive 53 biliary cancer 53 familial pancreatic cancer 53 idiopathic myelofibrosis 53 glioma rarer